LONDON, February 1 The latest issue of the journal Diabetic Hypoglycemia ( http:www.hypodiab.com) reviews the role of hypoglycemia in provoking crimes and misdemeanors. Professor Vincent Marks, a leading authority on the forensic aspects ...
Nicolas Bombourg Reportlinker Email: [email protected] US: (805)652-2626 Intl: +1 805-652-2626 ...
WALTHAM, Mass., Jan. 26 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Amylin/Eli Lilly/Alkermes' Byetta LAR earns Decision Resources' proprietary clinical ...
PRINCETON, N.J., Jan. 26 Novo Nordisk (NVO) announced that the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like ...
TEMPE, Ariz., Jan. 21 Intrinsic Bioprobes today announced the exclusive licensing of two novel biomarkers for diabetes to Ortho-Clinical Diagnostics, Inc. (Raritan, NJ). The biomarkers are modified forms of blood-circulating proteins and ...
R&D Program Targets Opportunities to Improve Glucose Control and Help People with Diabetes Lead Healthier Lives NEW YORK and FRANKLIN LAKES, N.J., Jan. 19 /PRNewswire-USNewswire/ -- The Juvenile Diabetes Research Foundation (JDRF) and ...
EDINA, Minn., Jan. 15 ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, launches the Assure Brilliance Program - a comprehensive service program for Long Term Care facilities and multi-patient use ...
PRINCETON, N.J., Jan. 14 A new analysis found that the cost of diabetes and pre-diabetes reached $218 billion in 2007, with the exploding number of cases of type 2 diabetes responsible for the majority of the costs. The National ...
Contact: Ron Geigle, 571- 435-0413 Helen Pettay, 910-795-1202 ...
WALTHAM, Mass., Jan. 6 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of type 2 diabetes, Bristol-Myers Squibb/AstraZeneca's Onglyza ...
Presence of high blood sugar in diabetic patients boosts cavity causing bacteria in saliva and significantly increases the risk of dental cavities.
A distinct type of immune cells was found in pancreas of type 1 diabetic people; the discovery offers target for early detection and prevention of diabetes.
WHO releases its first global guidelines for diabetes in pregnancy, aiming to prevent life-threatening complications and improve outcomes for millions of mothers and babies.
Workplace stress, long hours, and unhealthy habits are raising diabetes risk among India’s young professionals. Awareness and lifestyle changes are key.
Researchers found patients on GLP-1 drugs were less than half as likely to die within five years, hinting at a powerful new link between metabolic health and cancer survival.
MEDINDIA
English
हिन्दी
Español
français
中文